期刊文献+

骨髓增生异常综合征骨髓微环境的改变 被引量:1

Changes of bone marrow microenvironment of myelodysplastic syndromes
原文传递
导出
摘要 骨髓微环境是一个由造血干/祖细胞(HSPC)、非造血细胞以及细胞外基质和多种细胞因子等组成的复杂网状结构,其各成分相互作用以支持正常的造血。近来研究发现,骨髓微环境中的间充质干细胞(MSC)、髓源抑制性细胞、细胞因子功能紊乱以及造血干细胞的表观遗传学改变都可以影响正常造血,导致血液系统恶性疾病如骨髓增生异常综合征(MDS)的发生。已有动物模型证实了骨髓微环境在造血系统恶性疾病的发生和维持中起着重要作用。 Bone marrow microenvironment is a complex network consisting of hematopoietic stem/pro-genitor cells (HSPCs),non-hematopoietic cells,extracellular matrix and various cytokines.Its components interact to support normal hematopoiesis.Emerging evidence indicates that the dysfunction of mesenchymal stem cells,myeloid-derived suppressor cells,cytokines and the epigenetic alterations of HSPCs in the bone marrow microenvironment could influence normal hematopoiesis.Abnormal hematopoiesis contributes to the occurrence of hematological malignancies,such as myelodysplastic syndromes (MDS).Animal models have confirmed that bone marrow microenvironment plays an important role in the original generation and maintenance of malignant diseases of hematopoietic system.
出处 《国际肿瘤学杂志》 CAS 2016年第9期715-717,共3页 Journal of International Oncology
关键词 骨髓增生异常综合征 细胞因子类 间充质干细胞 Myelodysplastic syndromes Cytokines Mesenchymal stem cells
  • 相关文献

参考文献20

  • 1Xiong H, Yang XY, Han J, et al. Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenviron- merit of patients with myelodysplastic syndromes[ J]. Braz J Med Biol Res, 2015,48(3) : 207-213. DOI: 10. 1590/1414-431X20144051.
  • 2Bulycheva E, Rauner M, Medyouf H, et al. Myelodysplasia is in the niche: novel concepts and emerging therapies[ J]. Leukemia, 2015, 29 (2) : 259-268. DOI : 10. 1038/leu. 2014. 325.
  • 3Raaijmakers MH, Mukherjee S, Guo S, et al. Bone progenitor dys- function induces myelodysplasia and secondary leukaemia [ J ]. Nature, 2010, 464(7290) : 852-857. DOI: 10. 1038/nature08851.
  • 4Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem ceils- current trends and future prospective[ J ]. Biosci Rep, 2015, 35 (2) : e00191. DOI: 10. 1042/BSR20150025.
  • 5Falconi G, Fabiani E, Fianchi L, et al. Impairment of PI3K/AKT and WNT/beta-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes [ J ]. Exp Hematol, 2016, 44 ( 1 ) : 75-83. DOI: 10. 1016/j. exphem. 2015. 10. 005.
  • 6Blau O, Baldus CD, Hofmann WK, et al. Mesenchymal stromal cells of myelodysplastic syndrome and acute myelod leukemia patients have distinct genetic abnormalities compared with leukemic blasts [ J ]. Blood, 20ll, 118(20): 5583-5592. DOI: 10. 1182/blood-2011-03- 343467.
  • 7Geyh S, Oz S, Cadeddu RP, et al. Insufficient stromal support in MDS results from moleeular and functional deficits of mesenchymal stromal cells[J]. Leukemia, 2013, 27(9): 1841-1851. DOI: 10. 1038/leu. 2013. 193.
  • 8Johnson RC, Kurzer JH, Greenberg PL, et al. Mesenehymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival [ J ]. Am J Clin Pathol, 2014, 142(6) : 795-802. DOI: 10. 1309/AJCP71OPHKOTLSUG.
  • 9Cogle CR, Saki N, Khodadi E, et al. Bone marrow niche in the mye- lodysplastic syndromes[ J]. Leuk Res, 2015, 39 (10) : 1020-1027. DOI : 10. 1016/j. leukres. 2015.06. 017.
  • 10Chen X, Eksioglu EA, Zhou J, et al. Induction of myelodysplasia by myeloid-derived suppressor ceils[ J]. J Clin Invest, 2013, 123 ( 11 ) : 4595-4611. DOI : 10.1172/JCI67580.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部